Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

European Journal of Heart Failure, 2021
Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction

Woolley R., Ceelen D., Ouwerkerk W. et al.

Olink Target 96CVDPathophysiologyPatient StratificationBlood

Journal of Allergy and Clinical Immunology, 2021
Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis

Gülen T., Teufelberger A., Ekoff M. et al.

Immunological & Inflammatory DiseasesPatient StratificationPlasma

Scientific Reports, 2021
Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study

Patel R., Lam C., Svedlund S. et al.

Olink Target 96CVDPatient StratificationPlasma

Nature Medicine, 2021
A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity

Zhou S., Butler-Laporte G., Nakanishi T. et al.

Infectious DiseasesPatient Stratification

Acta Neurologica Scandinavica, 2021
Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment

Zhukovsky C., Herman S., Wiberg A. et al.

Olink Target 96NeurologyPathophysiologySerum

Inflammatory Bowel Diseases, 2021
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease

Verstockt S., Verstockt B., Machiels K. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum

Diabetes, 2021
Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes

Herder C., Maalmi H., Strassburger K. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPatient StratificationSerum

Cancers, 2021
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX

Stroes C., Schokker S., Molenaar R. et al.

Olink Target 96OncologyPatient StratificationPlasma

Scientific Reports, 2021
The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients

Wu P., Lin Y., Chiu Y. et al.

Olink Target 96CVDRenal DiseasesPathophysiologyPlasma

Biomarkers in Medicine, 2021
Associations of Serially Measured Pcsk9, Ldlr and Mpo with Clinical Outcomes in Heart Failure

Bouwens E., Schuurman A., Akkerhuis K. et al.

Olink Target 96CVDPatient StratificationPlasma

Computer Methods and Programs in Biomedicine, 2021
Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling

Yaşar ?., Çolak C., Yoloğlu S.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Cardiovascular Ultrasound, 2021
Pre- and postoperative left atrial and ventricular volumetric and deformation analyses in severe aortic regurgitation

Jenner J., Ilami A., Petrini J. et al.

Olink Target 96CVDPathophysiologyPlasma

Cancer Research, 2021
Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer

Dagnino S., Bodinier B., Guida F. et al.

Olink Target 96OncologyPatient StratificationPlasma

Scientific Reports, 2021
Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer

Jackson S., Van De Wyngard V., Pfeiffer R. et al.

Olink Target 96OncologyPatient StratificationSerum

Clinical Cancer Research, 2021
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Monjazeb A., Giobbie-Hurder A., Lako A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum

Nature Medicine, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Rozeman E., Hoefsmit E., Reijers I. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Journal of Inherited Metabolic Disease, 2021
Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures

Abdennadher M., Inati S., Soldatos A. et al.

Olink Target 96NeurologyPathophysiologyCSF

Psychoneuroendocrinology, 2021
Autoantibodies against the C-terminus of Lipopolysaccharide binding protein are elevated in young adults with psychiatric disease

Just D., Rasmusson A., Nilsson P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

International Journal of Molecular Sciences, 2021
Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis

de Jesús-Gil C., Sans-de San Nicolàs L., Ruiz-Romeu E. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyPlasma

PLOS Medicine, 2021
Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

Chua W., Law J., Cardoso V. et al.

CVDPatient StratificationPlasma

2798 publications